As of 31 Dec 2025, 1 institutional investors reported holding 12,700 shares of SAREPTA THERAPEUTICS INC - CALL.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 12,700 | $273,000 | +$273,000 | $21.52 | 1 |
| 2025 Q3 | $19.27 | 0 | |||
| 2025 Q2 | $17.10 | 0 | |||
| 2025 Q1 | $63.82 | 0 | |||
| 2024 Q4 | $121.59 | 0 | |||
| 2024 Q3 | $124.89 | 0 | |||
| 2024 Q2 | $158.00 | 0 | |||
| 2024 Q1 | $129.46 | 0 | |||
| 2023 Q4 | $96.43 | 0 | |||
| 2023 Q3 | $121.22 | 0 | |||
| 2023 Q2 | $114.52 | 0 | |||
| 2023 Q1 | $137.83 | 0 | |||
| 2022 Q4 | $129.58 | 0 | |||
| 2022 Q3 | $110.54 | 0 | |||
| 2022 Q2 | $74.96 | 0 | |||
| 2022 Q1 | $78.12 | 0 | |||
| 2021 Q4 | $90.05 | 0 | |||
| 2021 Q3 | $92.48 | 0 | |||
| 2021 Q2 | $77.74 | 0 | |||
| 2021 Q1 | $74.53 | 0 | |||
| 2020 Q4 | $170.50 | 0 | |||
| 2020 Q3 | $14042.88 | 0 | |||
| 2020 Q2 | $160.34 | 0 | |||
| 2020 Q1 | $97.82 | 0 | |||
| 2019 Q4 | $129.04 | 0 | |||
| 2019 Q3 | $75.32 | 0 | |||
| 2019 Q2 | $151.95 | 0 | |||
| 2019 Q1 | $119.19 | 0 | |||
| 2018 Q4 | $5510.57 | 0 | |||
| 2018 Q3 | $8156.13 | 0 | |||
| 2018 Q2 | $6674.70 | 0 | |||
| 2018 Q1 | $886.02 | 0 | |||
| 2017 Q4 | $55.64 | 0 | |||
| 2017 Q3 | $549.31 | 0 | |||
| 2017 Q2 | $120.00 | 0 | |||
| 2017 Q1 | $82.98 | 0 | |||
| 2016 Q4 | $27.45 | 0 | |||
| 2016 Q3 | $61.41 | 0 | |||
| 2016 Q2 | $19.07 | 0 | |||
| 2016 Q1 | $19.52 | 0 | |||
| 2015 Q4 | $493.63 | 0 | |||
| 2015 Q3 | $309.25 | 0 | |||
| 2015 Q2 | $449.45 | 0 | |||
| 2015 Q1 | $63.29 | 0 | |||
| 2014 Q4 | $28.79 | 0 | |||
| 2014 Q3 | $21.10 | 0 | |||
| 2014 Q2 | $29.79 | 0 | |||
| 2014 Q1 | $24.03 | 0 |